Citeline leveraging Saama`s artificial intelligence to offer customers a complete understanding of the clinical trial landscape LONDON, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Today, Citeline, part of ...
The industry`s most comprehensive clinical trial data and analysis, now delivered to better fit customers` individual needs and workflows LONDON, June 19, 2017 (GLOBE NEWSWIRE) -- Informa Pharma ...
New collaboration integrates Citeline's comprehensive trial databases with Evinova's AI-native Study Designer to optimize decisions to improve study outcomes Evinova, a global health tech company with ...
NEW YORK, May 23, 2023 (GLOBE NEWSWIRE) -- With new Food and Drug Administration (FDA) guidance, study sponsors are no longer viewing clinical trial diversity as “nice to have” but as a “must have.” ...
In March 2026, Citeline announced an expanded strategic partnership with Recursion Pharmaceuticals to integrate Citeline's real-world data and evidence into Recursion’s tech-enabled drug discovery and ...
(MENAFN- GlobeNewsWire - Nasdaq) Clinical Trial Disclosure Solution Harmonizes Data Across Multiple Regions, Registries NEW YORK, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Submitting clinical trial ...
NEW YORK and SALT LAKE CITY, March 31, 2026 (GLOBE NEWSWIRE) — Citeline, a leader in clinical solutions for the life sciences industry, today announced an expanded strategic partnership with Recursion ...
Clinical Trial Disclosure Solution Harmonizes Data Across Multiple Regions, Registries NEW YORK, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Submitting clinical trial disclosures across different regions can be ...
NEW YORK, May 23, 2023 (GLOBE NEWSWIRE) -- With new Food and Drug Administration (FDA) guidance, study sponsors are no longer viewing clinical trial diversity as "nice to have" but as a "must have." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results